Zydus Lifesciences to commercialize OncoStem’s CanAssist Breast test
Zydus Lifesciences has secured exclusive marketing rights to CanAssist Breast, a prognostic test for breast cancer patients in the early stages, from Bengaluru-based OncoStem. According to Zydus Lifesciences, CanAssist Breast will enable clinicians in taking a call if the patient requires chemotherapy or not. By leveraging OncoStem’s proprietary artificial intelligence/machine learning methods, CanAssist Breast can […]